BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Italian Association for the Study of the Liver (AISF). AISF position paper on HCV in immunocompromised patients. Dig Liver Dis 2019;51:10-23. [PMID: 30366813 DOI: 10.1016/j.dld.2018.09.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Nangia G, Borges K, Reddy KR. Use of HCV‐infected organs in solid organ transplantation: An ethical challenge but plausible option. J Viral Hepat 2019;26:1362-71. [DOI: 10.1111/jvh.13130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 Baronciani D, Casale M, De Franceschi L, Graziadei G, Longo F, Origa R, Rigano P, Pinto V, Marchetti M, Gigante A, Forni GL. Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm. Hemasphere 2021;5:e555. [PMID: 33969274 DOI: 10.1097/HS9.0000000000000555] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Magrì S, Chessa L, Demurtas M, Cabras F, Mocci G. Review article: safety of new biologic agents for inflammatory bowel disease in the liver. Eur J Gastroenterol Hepatol 2021;33:623-30. [PMID: 33470695 DOI: 10.1097/MEG.0000000000002076] [Reference Citation Analysis]